SB 163 updates South Dakota's prescription drug pricing transparency law by clarifying which organizations must follow the transparency rules—including nonprofits, health insurers, employers, and labor unions that provide health coverage to state residents. The bill also refines definitions of key terms like "generic drug" and "labeler" to ensure the law applies consistently across the state's health coverage system.
This bill does not directly amend codified state law.
Senate Reconsidered Failed, YEAS 16, NAYS 19. S.J. 372
Senate Intent to reconsider S.J. 341
Senate Do Pass Amended Failed, YEAS 17, NAYS 17. S.J. 341
Senate Motion to amend S.J. 340
Senate Deferred to another day S.J. 304
Health and Human Services Do Pass Amended Passed, YEAS 5, NAYS 2.
Health and Human Services Motion to amend
Health and Human Services Scheduled for hearing
First read in Senate and referred to Senate Health and Human Services S.J. 129
Michael Diedrich
Prime sponsor · Sen.
R
Cosponsors
Do Pass Amended
Reconsidered
Health and Human Services — Do Pass Amended